CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
The new online Learning Center with new content can still be found under the “Training” folder on ...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...